The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection

There is considerable heterogeneity in clinical behavior and survival outcomes in patients with cholangiocarcinoma (CCA), and the prognosis of CCA patients is poor. We proposed lymphocyte to monocyte ratio (LMR) as a novel prognostic element for CCA patients with hepatic resection in present study.

[1]  S. Shiozawa,et al.  [Significance of Transitions in Neutrophil-to-Lymphocyte Ratio before and after Transcatheter Arterial Chemoembolizaton for Hepatocellular Carcinoma]. , 2021, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  A. Matsuda,et al.  The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab , 2021, AntiCancer Research.

[3]  S. Raman,et al.  Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  T. Chiu,et al.  Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma , 2020, PloS one.

[5]  Jinming Yu,et al.  Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases. , 2020, Future oncology.

[6]  Wei Wei,et al.  Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[7]  F. Bray,et al.  Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends , 2020, International journal of cancer.

[8]  Hui Zhang,et al.  Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy , 2019, BMC Cancer.

[9]  Yongping Song,et al.  The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma , 2019, Cancer Cell International.

[10]  Yi-yao Xu,et al.  Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma , 2019, Cancer management and research.

[11]  Y. Ogata,et al.  Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma , 2019, Oncology.

[12]  Nansheng Cheng,et al.  Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma , 2019, Journal of Gastrointestinal Surgery.

[13]  G. Kawasaki,et al.  Prognostic Significance of Pretreatment Lymphocyte–to–Monocyte Ratio in Patients with Tongue Cancer , 2018, AntiCancer Research.

[14]  Hwa Young Choi,et al.  Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database , 2018, Gut and liver.

[15]  G. Spolverato,et al.  The impact of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio among patients with intrahepatic cholangiocarcinoma , 2018, Surgery.

[16]  J. Cui,et al.  Present and future of cancer immunotherapy: A tumor microenvironmental perspective. , 2018, Oncology letters.

[17]  J. Brosseau,et al.  Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis , 2018, The Journal of clinical investigation.

[18]  G. Gores,et al.  Cholangiocarcinoma — evolving concepts and therapeutic strategies , 2018, Nature Reviews Clinical Oncology.

[19]  K. Majidzadeh-A,et al.  Study of the tumor microenvironment during breast cancer progression , 2017, Cancer Cell International.

[20]  C. Gilles,et al.  EMT and inflammation: inseparable actors of cancer progression , 2017, Molecular oncology.

[21]  Y. Xia,et al.  Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type , 2017, Journal of Cancer.

[22]  S. Clarke,et al.  Cancer-related inflammation and treatment effectiveness. , 2014, The Lancet. Oncology.

[23]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[24]  G. Gores,et al.  Pathogenesis, diagnosis, and management of cholangiocarcinoma. , 2013, Gastroenterology.

[25]  A. Loukas,et al.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. , 2012, Trends in parasitology.

[26]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[27]  Leida Zhang,et al.  Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. , 2010, Human immunology.

[28]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[29]  J. Blay,et al.  Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. , 2009, Cancer research.

[30]  R. Parks,et al.  Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. , 2007, HPB : the official journal of the International Hepato Pancreato Biliary Association.